Edan Instruments Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Hao Zhang

Chief executive officer

CN¥2.0m

Total compensation

CEO salary percentage	n/a
CEO tenure	14.3yrs
CEO ownership	21.1%
Management average tenure	no data
Board average tenure	12.8yrs

Recent management updates

Recent updates

CEO

Hao Zhang (60 yo)

14.3yrs

Tenure

CN¥2,016,900

Compensation

Mr. Hao Zhang serves as the Chairman and President at Edan Instruments, Inc. Mr. Zhang has a Master’s Degree.

Board Members

Name	Position	Tenure	Compensation	Ownership
Hao Zhang	Chairman & President	14.3yrs	CN¥2.02m	21.05% CN¥ 1.0b
Youdong Zu	CFO, VP	14.3yrs	CN¥1.62m	17.27% CN¥ 859.9m
Xicheng Xie	VP & Non-Independent Director	14.3yrs	CN¥1.62m	17.18% CN¥ 855.3m
Yang Su	Independent Director	14.3yrs	CN¥150.00k	no data
Chun Zhou	Chairman of Supervisory Board	11.3yrs	CN¥98.80k	no data
Chun Li	Independent Director	14.3yrs	CN¥150.00k	no data
Hongchao Wang	Non-Employee Supervisor	5.6yrs	no data	no data
Quanlu Zheng	Independent Director	2.2yrs	CN¥150.00k	no data
Yirong Zhou	Non-Employee Supervisor	4.1yrs	no data	no data
Shixin Yuan	Independent Outside Director	1.3yrs	CN¥104.20k	no data

12.8yrs

Average Tenure

59.5yo

Average Age

Experienced Board: 300206's board of directors are seasoned and experienced ( 12.8 years average tenure).

Edan Instruments Management

Management criteria checks 2/4

Key information

Recent management updates

Edan Instruments, Inc., Annual General Meeting, Apr 22, 2024

High number of new directors

High number of new directors

Recent updates

Edan Instruments, Inc. to Report First Half, 2024 Results on Aug 30, 2024

First quarter 2024 earnings released: EPS: CN¥0.066 (vs CN¥0.24 in 1Q 2023)

Edan Instruments, Inc. to Report Q1, 2024 Results on Apr 26, 2024

Edan Instruments, Inc., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings released: EPS: CN¥0.38 (vs CN¥0.40 in FY 2022)

New minor risk - Share price stability

Investor sentiment improves as stock rises 33%

Investor sentiment deteriorates as stock falls 16%

Edan Instruments, Inc. to Report Fiscal Year 2023 Results on Mar 29, 2024

Edan Instruments, Inc. Focus on Medical Technology Advancement Shines At Medica 2023

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.051 (vs CN¥0.068 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.17 in 2Q 2022)

Edan Instruments, Inc. to Report First Half, 2023 Results on Aug 23, 2023

First quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.085 in 1Q 2022)

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: CN¥0.068 (vs CN¥0.11 in 3Q 2021)

Edan Instruments, Inc. Showcases Its First Molecular Diagnostics Analysis System, ClariLight CL30, at Medlab Asia & Asia Health 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.10 in 2Q 2021)

Edan Instruments, Inc. Launches i20

High number of new directors

High number of new directors

First quarter 2022 earnings released: EPS: CN¥0.085 (vs CN¥0.21 in 1Q 2021)

Edan Instruments, Inc. Announces Cash Dividend for the Year 2021, Payable on 29 April 2022

Edan Instruments, Inc. Approves Distribution for 2021

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.28 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.10 (vs CN¥0.67 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.14 in 1Q 2020)

Edan Instruments, Inc. Announces Profit Distribution Proposal for 2020

Full year 2020 earnings released: EPS CN¥1.12 (vs CN¥0.23 in FY 2019)

Investor sentiment deteriorated over the past week

Edan Instruments, Inc. to Report Fiscal Year 2020 Results on Mar 15, 2021

CEO

Tenure

Compensation

Board Members

Average Tenure

Average Age